Simplified approaches in the treatment of acute malnutrition involve modifications to existing protocols to optimize effectiveness, quality, and cost-efficiency. These approaches include family MUAC screening, CHW-led treatment, reduced follow-up visits, expanded admission criteria, single treatment

1 views • 15 slides

The February 2024 NYSDOH AIDS Institute Clinical Guidelines Program focuses on assisting clinicians in engaging with patients about opioid use disorder (OUD) treatment goals, emphasizing overdose prevention, providing updated information on available treatment options, and offering recommendations f

2 views • 24 slides

Clinical guidelines provide evidence-based recommendations for treating and curing chronic HCV infection in adults to improve treatment rates, reduce morbidity and mortality, and support the New York State Hepatitis C Elimination Plan. Recommendations include considerations in HCV treatment initiati

0 views • 28 slides

LiveRx Study aims to evaluate the impact of a collaborative program involving community pharmacies and organizations in treating HCV in Alberta. By leveraging pharmacist-led interventions, the initiative focuses on increasing HCV screening, diagnosis, and linkage to care, ultimately aiming to eradic

2 views • 13 slides

Treatment Supporter Scheme provides assistance to TPT beneficiaries in completing their treatment. Treatment Supporters can be various individuals including Medical Officers, MPWs, and community volunteers. Their role involves educating beneficiaries about TPT treatment, ensuring medication adherenc

1 views • 21 slides

Cedar Recovery is a nonresidential substitution-based treatment center focusing on opiate addiction in Knox County, Tennessee. With a strong emphasis on Office Based Opioid Treatment (OBOT) services, Cedar Recovery, led by reputable professionals like Dr. Stephen Loyd, aims to address the growing ne

4 views • 19 slides

Did you know that seeking a second opinion from an experienced cancer specialist in Pune could be the key to unlocking more effective cancer treatment options? When you are diagnosed with cancer and researching about the treatment options then you must take a second opinion for your treatment for be

1 views • 3 slides

We offer best skin care treatment in jubilee hills, hyderabad. specialized in fillers treatment, injectible fillers treatment, we have top class dermatologist for dermal fillers treatment

0 views • 2 slides

Explore the intricate world of ocular proton therapy treatment planning with Dr. Linda Mortimer, PhD. Discover the fundamental elements of an ocular treatment plan, main goals of treatment planning, an overview of dedicated ocular Treatment Planning Systems (TPS), planning workflows, choice of TPS,

1 views • 12 slides

Heart disease is one of the most serious problems that require constant care. Heart treatment cost in India has increased significantly with time. In such a situation, heart treatment is being taken very seriously. A healthy diet must be followed every day. You have to use fiber, heart-healthy eleme

4 views • 2 slides

Hua Jing Tang TCM serves the Best treatment for Acupuncture in Geylang. Their experienced team offers a comprehensive range of services including Physician Consultation, Acupuncture Treatment, Bloodletting, Cupping, Sprain bandaging, Chinese herbal medicines, Tuina, Scraping, Cupping, pull tendons,

3 views • 6 slides

These guidelines aim to increase the number of clinicians offering evidence-based treatment for individuals with Alcohol Use Disorder (AUD), engage more New York State residents in treatment, reduce alcohol-related deaths, and promote a harm reduction approach. They address the prevalence of binge a

1 views • 18 slides

The Housing Choice Voucher (HCV) Homeownership Program helps low-income, first-time homebuyers by providing monthly housing assistance payments. This presentation covers key aspects such as program overview, steps to develop the program, operations, counseling, eligible housing, inspections, financi

0 views • 71 slides

Reverse osmosis (RO) is a treatment method used in challenging water treatment situations to remove contaminants effectively. It requires pre-treatment and remineralization, making it suitable for mineral and chemical contamination. RO systems need careful maintenance to prevent fouling and membrane

0 views • 6 slides

Referral to Treatment (RTT) Quality Standards, also known as RTT 18 Weeks, is a vital component of the NHS Constitution that guarantees patients a legal right to timely diagnosis and treatment within 18 weeks of referral. It encompasses various stages in a healthcare pathway, each assigned an RTT co

1 views • 12 slides

TB Treatment Supporter Scheme involves assigning individuals such as Medical Officers, MPWs, community volunteers, and even a patient's relative to support TB patients in completing their treatment. Treatment Supporters help in medication adherence, conducting follow-ups, and referring patients for

0 views • 16 slides

Wastewater treatment involves primary and secondary processes to reduce suspended solids and BOD levels. Primary treatment utilizes sedimentation tanks followed by sludge thickening, while secondary treatment involves biological methods such as trickling filters. Various secondary treatment methods

0 views • 15 slides

Treatment processes for faecal sludge management involve various stages including preliminary treatment, primary treatment, secondary treatment, and tertiary treatment. Each stage employs mechanical, biological, and chemical processes to separate, decompose, and remove contaminants from the sludge,

0 views • 7 slides

In aquatic systems, wastewater treatment involves bacterial metabolism and sedimentation, with aquatic plants playing a role in improving treatment capabilities. This article discusses the functions of aquatic plants in treatment systems and the categories of wetlands used for wastewater treatment,

1 views • 15 slides

Explore the latest advancements in the treatment of Hepatitis C virus (HCV) in HIV-infected individuals through a detailed presentation by Dr. Kara W. Chew. Learn about the initial evaluation for HCV, treatment options for different genotypes, management of advanced fibrosis, recommended approaches

0 views • 9 slides

The benchmark process conducted by the Maravelias Research Group in Chemical and Biological Engineering focuses on wastewater treatment efficiency and performance metrics. The process includes various stages such as secondary treatment, preliminary treatment, primary treatment, disinfection, and bio

0 views • 7 slides

PASAN (Prisoners with HIV/AIDS Support Action Network) in Ontario exclusively works with prisoners and ex-prisoners to provide support, education, and advocacy related to HIV/HCV and harm reduction. They aim to ensure healthcare access and continuity of care for prisoners living with HIV/HCV, combat

0 views • 20 slides

Discussing the goals, treatment options, and global impact of Hepatitis C in individuals with HIV infection, this presentation by Dr. David L. Thomas from Johns Hopkins Medical Institutions sheds light on important aspects such as mortality projections, WHO elimination goals, and targets for hepatit

0 views • 40 slides

The 2022 report on Hepatitis C in England shows a continued decline in the prevalence of chronic HCV infection, with around 81,000 individuals estimated to be affected in 2020. The report also highlights the distribution of infections among individuals with different drug injecting histories. Data f

0 views • 41 slides

Today's webinar covers updates on 2024 funding, income protections, and program resources. Details include new funding timelines, highlights of the 2024 appropriations, combating source of income discrimination, and more. Stay informed and engaged with the latest developments in the HCV program.

0 views • 17 slides

The Canadian Task Force on Preventive Health Care (CTFPHC) released recommendations on Hepatitis C screening for adults in 2017. The guidelines provide an overview of screening methods, key findings, implementation considerations, and conclusions. Those at higher risk for HCV in Canada include indiv

0 views • 38 slides

This collection of images and data discusses the importance of monitoring thyroid function after head and neck cancer treatment, specifically focusing on post-treatment thyroid function tests, audits of practices in head and neck units, thyroid function post laryngectomy, and the significance of det

0 views • 11 slides

In the absence of an HCV vaccine, individuals cured of HCV are still at risk of reinfection, particularly among HIV-co-infected populations. This study aims to examine the risk of reinfection within 2 years of achieving sustained virological response in Europe. Regional differences, treatment regime

0 views • 19 slides

The ATTAIN study compared simeprevir and telaprevir in previous non-responders with genotype 1 HCV. The study included 379 patients with simeprevir and 384 with telaprevir, focusing on SVR12 as the primary endpoint. Baseline characteristics, treatment regimens, patient disposition, and virologic out

0 views • 6 slides

This detailed profile showcases Rajesh Bhagat's extensive academic and professional achievements in environmental engineering, focusing on wastewater treatment. It covers various treatment processes such as secondary treatment, sludge digestion, preliminary treatment, and primary treatment. Referenc

0 views • 53 slides

Dr. Fred Stephen Sarfo's research on Hepatitis C in Ghana reveals a notable sero-prevalence of the virus across various populations such as blood donors, prisons inmates, and more. The studies show varying HCV antibody frequencies, highlighting the need for continued surveillance and targeted interv

0 views • 25 slides

The C-EDGE.TN Study evaluated the efficacy of grazoprevir/elbasvir treatment in patients with HCV infection, specifically genotype 1, 4, or 6. The study included 316 patients and aimed to achieve SVR12 rates superior to historical standards. The treatment was well-tolerated, with high SVR12 rates ac

0 views • 9 slides

The CORAL-I trial evaluated the safety and efficacy of the 3D regimen (ombitasvir-paritaprevir-ritonavir + dasabuvir) combined with ribavirin for 24 weeks in liver transplant recipients with recurrent HCV genotype 1. The study included treatment-naive individuals after transplantation, with specific

0 views • 8 slides

This study, supervised by Dr. Christina Greenaway, aims to estimate and compare healthcare utilization in Quebec immigrants and non-immigrants diagnosed with chronic Hepatitis C infection. The research seeks to identify predictors of all-cause and liver-related healthcare utilization. With rising he

0 views • 25 slides

The C-SALT study evaluated the efficacy of grazoprevir and elbasvir in patients with genotype 1 chronic HCV infection and Child-Pugh B cirrhosis. The primary endpoint was achieving sustained virologic response at 12 weeks. The study included treatment-naive and pre-treated patients with IFN-based re

0 views • 7 slides

The ALLY-3+ Trial investigates the efficacy of daclatasvir, sofosbuvir, and ribavirin in patients with chronic HCV GT-3 and advanced liver disease. This Phase 3 study compared 12 versus 16 weeks of treatment in treatment-naive or experienced individuals. Results showed promising SVR12 rates and favo

0 views • 9 slides

Study on the efficacy of Daclatasvir and Sofosbuvir in treating Hepatitis C Virus (HCV) Genotype 3, involving treatment-naive and treatment-experienced patients. The Phase 3 trial showcased promising results in achieving SVR12, with detailed patient characteristics, drug dosing, and baseline charact

0 views • 10 slides

In the study of therapeutic trials in HIV/HCV coinfection between 2014-2015, notable trials included ION-4 with LDV/SOF treatment for 12 weeks in HCV/HIV co-infection patients, showing high SVR rates in both treatment-naive and experienced patients. Another trial, Ally-2, involved Daclatasvir and So

0 views • 15 slides

The content discusses various statistical methods to analyze treatment means in experimental studies, including KNNL models, main effects plots, inference for individual treatment means, comparing two treatment means, and contrasts among treatment means. It covers topics such as parameter estimation

0 views • 25 slides

This presentation by Dr. Ricardo A. Franco focuses on the challenges faced in managing and treating patients with HIV/Hepatitis C virus coinfection. It discusses the burden of HCV mono-infection and HIV/HCV co-infection, the impact of HIV co-infection on survival in HCV-related cirrhosis, and the ro

0 views • 26 slides